Yao Ming Kangde (603259): Backend maintains high growth and TIDES business continues to expand
Yao Ming Kangde (603259) Company Brief Evaluation Report: Steady Growth in Performance, Outstanding Business Performance by TIDES
Yao Ming Kangde (603259): Revenue and profit increased steadily throughout the year, and TIDES business orders increased significantly
Yao Ming Kangde (603259): 23-year performance achieved steady growth, D&M business continues to contribute to performance growth
Yao Ming Kangde (603259): Integrated platforms drive steady business growth and are optimistic about long-term development prospects
Yao Ming Kangde (603259) 2023 Report Review: Year-round revenue and profit increased steadily, and TIDES business orders increased significantly
Yao Ming Kangde (603259): Performance is in line with expectations, strong growth in the new molecule business
Yao Ming Kangde (603259): Steady growth in performance, and the peptide business continues to gain strength
Yao Ming Kang De (603259): Optimistic about integrated toughness under disturbances
Yao Ming Kangde (603259): Performance is in line with expectations and has maintained steady growth for 24 years
Yao Ming Kangde (603259) 2023 Annual Report Review: Performance is in line with expectations, TIDES business is growing rapidly
Yao Ming Kangde (603259): Forward-looking layout highlights management resilience and continuous improvement in operating efficiency
Yao Ming Kangde (2359.HK): It will take some time for downstream demand to recover, and peripheral uncertainties will increase
Yao Ming Kangde (603259): Performance is in line with expectations, new businesses are developing rapidly
Yao Ming Kangde (603259) 2023 Annual Report Review: Various businesses are developing steadily, and the CDMO business continues to gain strength
Yao Ming Kangde (603259): 2023 results are in line with expectations and maintain a 30% cash dividend ratio
Yao Ming Kangde (603259) Company Information Update Report: Regular business is developing steadily, and emerging businesses such as TIDES are growing strongly
Nomura Adjusts Wuxi Apptec's Price Target to 62.75 Yuan From 99.16 Yuan, Keeps at Buy
Yao Ming Kangde (603259): Performance is in line with expectations and is expected to grow steadily in 2024
Yao Ming Kangde (603259) 2023 Annual Report Review: Peptide Molecular Pipelines and Production Capacity Accelerate Growth, and the Company's Profitability Continues to Improve
No Data